HHS recently announced the government’s partnerships with large chain pharmacies and networks to boost access to COVID-19 vaccines across the US.
The partnership program will cover nearly 60...
HHS and the Department of Defense (DoD) jointly announced a $12.7 million contract to increase domestic production for two rapid point-of-care COVID-19 tests.
The contract is with InBios...
FDA recently approved Verklury as the first COVID-19 treatment. The approval signs off on using the drug also known as remdesivir has been signed in adults and pediatric patients 12 years of age or...
Thermo Fisher Scientific recently announced it has received an expansion of its emergency use authorization for a COVID-19 testing kit to include an additional sample collection method provided by...
Vir Biotechnology and GSK recently announced the global expansion of a Phase 3 study evaluating their COVID-19 antibody, VIR-7831.
The COMET-ICE study will evaluate VIR-7831 in patients who are at...
Sixty-four higher-income economies recently joined the COVAX Facility, a global COVID-19 response effort that ensures governments and manufacturers have access to COVID-19 vaccines, according to an...
Sanofi and GSK recently finalized an agreement with the European Commission (EC) for the supply of up to 300 million doses of their COVID-19 vaccine, once the vaccine is approved.
The agreement will...
Nearly half (51 percent) of Americans said they would definitely or probably get a COVID-19 vaccine if it were available today, while 49 percent said they definitely or probably would not, according to...
COVID-19 vaccines are being developed at a quick pace, but a broken supply chain could derail this momentum. A new report from PricewaterhouseCoopers (PwC), however, uncovered three steps drug...
Last week, HHS issued guidance under the Public Readiness and Emergency Preparedness Act (PREP Act) to expand access to safe and effective COVID-19 vaccines when they become available.
The...
FDA recently issued an emergency use authorization to Abbott for the first COVID-19 antigen test where results can be read directly from the testing card.
The BinaxNOW Ag Card is fast and...
EHR-based clinical trials can accelerate the pace of research discoveries and generate sufficient evidence to inform treatment strategies, according to a recent article from the Clinical Journal...
Today, CMS issued a proposed rule that would create a new, accelerated Medicare coverage process for innovative products that FDA deems “breakthrough,” including new implants or gene-based...
FDA recently approved Trevena Inc.’s Olinvyk (oliceridine), an opioid used to manage severe acute pain in adults who require an intravenous opioid and who have been unresponsive to alternative...
FDA recently announced that it is requiring label changes for opioid pain medicines and medicines used to treat opioid use disorder (OUD).
Updated labels for the prescription drugs will need to say,...
FDA recently reissued an Emergency Use Authorization (EUA) to Quest Diagnostics for its sample COVID-19 pooled testing tool.
For more coronavirus updates, visit our resource page, updated twice...
Scientists from the University of Oxford’s Department of Engineering Science and Oxford Suzhou Centre for Advanced Research (OSCAR) recently developed a new company to launch a COVID-19 rapid...
Pfizer and BioNTech were recently granted FDA Fast Track designation for two of the companies’ four investigational COVID-19 vaccine candidates from their BNT162 mRNA-based vaccine program,...
Pfizer recently announced that it pledged $100 million to the Antimicrobial Resistance (AMR) Action Fund to address the vital public health need for new antibiotics due to the rapid rise of...
FDA recently issued an Emergency Use Authorization (EUA) for a rapid COVID-19 antigen diagnostic test that can be used at the point of care.
For more coronavirus updates, visit our resource page,...
